Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa

NCT03730584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: Ropivacaine
BIOLOGICAL: Blood test

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]